Is a complete TSXV/RX research report available?

No complete published report is available for tsxv/RX (TSXV/RX) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

tsxv/RX stock profile: metrics, valuation and analysis

Market cap	177.4M
Revenue (ttm)	55.7M
Net income (ttm)	9.9M
EPS (ttm)	CA$0.85
Shares out	11.3M
P/E (trailing)	18.4x
P/E (forward)	15.2x
Dividend	CA$0.22 (1.40%)
Volume	4,430
Beta	0.64

All TSXV/RX indicators

Market & fundamental data

Available fields

249

Groups with data

Currency

CAD

Showing 249 of 249 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Canada
Country code	CA
Enterprise value	CAD 171.6M
Exchange	TSX Venture Exchange
Financial currency	CAD
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Industry PE Fwd	21.87
Isin	CA0906901081
Last refreshed	2026-09-11
Market cap	CAD 177.4M
Price	CAD 15.65
Price currency	CAD
Sector	Healthcare
Sic	2834
Symbol	tsxv/RX
Website	https://www.biosyent.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	5.56%
EV Earnings	17.39x
EV/EBIT	12.98x
EV/EBITDA	11.37x
EV/FCF	14.98x
EV/Sales	3.08x
FCF yield	6.46%
Forward P/E	15.16x
P/B ratio	3.87x
P/E ratio	18.37x
P/S ratio	3.19x
PE Ratio10 Y	19.53x
PE Ratio3 Y	16.3x
PE Ratio5 Y	16.45x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	23.74%
EBITDA Margin	26.73%
FCF margin	20.58%
Gross margin	73.38%
Gross Profit	CAD 40.9M
Gross Profit Growth	32.24%
Gross Profit Growth Q	76.55%
Gross Profit Growth3 Y	20.01%
Gross Profit Growth5 Y	14.84%
Net Income	CAD 9.9M
Net Income Growth	19.48%
Net Income Growth Q	41.19%
Net Income Growth Qo Q	21.52%
Net Income Growth Quarters	7%
Net Income Growth Years	3%
Net Income Growth3 Y	22.94%
Net Income Growth5 Y	18.05%
Pretax Margin	24.04%
Profit Margin	17.73%
Profitable Quarters	CAD 61
Profitable Years	16
ROA	15.9
Roa5y	13.27
ROCE	28.33
ROE	23.65
Roe5y	20.35
ROIC	24.56
Roic5y	83.4

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	7.46%
Cagr15y	30.94%
Cagr1y	32.44%
Cagr20y	26.21%
Cagr3y	26.68%
Cagr5y	17.24%
Div CAGR3	10.35%
EPS Growth	20.37
EPS Growth Q	39.21
EPS Growth Qo Q	21.29
EPS Growth Quarters	1
EPS Growth Years	3
EPS Growth3 Y	25.81
EPS Growth5 Y	20.62
FCF Growth	-3.8%
FCF Growth Q	-27.31%
FCF Growth Qo Q	-6.84%
FCF Growth3 Y	28.6%
FCF Growth5 Y	21.82%
OCF Growth	-3.9%
OCF Growth Q	-27.21%
OCF Growth Qo Q	-7.16%
OCF Growth10 Y	10.67%
OCF Growth3 Y	28.56%
OCF Growth5 Y	21.71%
Revenue Growth	40.91x
Revenue Growth Q	95.23x
Revenue Growth Qo Q	42.89x
Revenue Growth Quarters	13x
Revenue Growth Years	3x
Revenue Growth3 Y	24.72x
Revenue Growth5 Y	16.26x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CAD 1.07
Assets	CAD 60.5M
Cash	CAD 8.9M
Current Assets	CAD 28.5M
Current Liabilities	CAD 13.8M
Debt	CAD 3.1M
Debt EBITDA	CAD 0.21
Debt Equity	CAD 0.07
Debt FCF	CAD 0.27
Equity	CAD 45.8M
Interest Coverage	124
Liabilities	CAD 14.6M
Long Term Assets	CAD 31.9M
Long Term Liabilities	CAD 820,315
Net Cash	CAD 5.8M
Net Cash By Market Cap	CAD 3.27
Net Cash Growth	-70.13%
Net Debt EBITDA	CAD -0.39
Net Debt Equity	CAD -0.13
Net Debt FCF	CAD -0.51
Tangible Book Value	CAD 19.5M
Tangible Book Value Per Share	CAD 1.72
WACC	7.69

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.07
Inventory Turnover	1.9
Net Working Capital	CAD 8.2M
Quick ratio	1.13
Working Capital	CAD 14.7M
Working Capital Turnover	CAD 2.76

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.72%
Dividend Growth	10.26%
Dividend Growth Years	3%
Dividend per share	CAD 0.22
Dividend Years	5
Dividend Yield	1.4%
Ex Div Date	2026-08-31
Last Dividend	CAD 0.06
Payout Frequency	Quarterly
Payout Ratio	24.01%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	105.23%
1Y total return	32.41%
200-day SMA	14.13
3Y total return	103.33%
50-day SMA	15.02
50-day SMA vs 200-day SMA	50over200
5Y total return	121.43%
All Time High	16.25
All Time High Change	-3.69%
All Time High Date	2026-09-01
All Time Low	0.01
All Time Low Change	156,400%
All Time Low Date	2001-12-13
ATR	0.27
Beta	0.64
Beta1y	0.94
Beta2y	0.84
Ch YTD	22.94
High	15.69
High52	16.25
High52 Date	2026-09-01
High52ch	-3.69%
Low	15.64
Low52	10.65
Low52 Date	2025-11-20
Low52ch	46.95%
Ma50ch	4.19%
Price vs 200-day SMA	10.8%
RSI	54.64
RSI Monthly	68.33
RSI Weekly	64.48
Sharpe ratio	0.95x
Sharpe Ratio3y	0.93x
Sharpe Ratio5y	0.53x
Sortino ratio	1.92
Sortino Ratio3y	1.76
Sortino Ratio5y	1.03
Total Return	2.13%
Tr YTD	24.3
Tr15y	5,604.54%
Tr1m	4.7%
Tr1w	-1.45%
Tr3m	14.63%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	9,129,905%
Net Borrowing	1,668,414
Shares Insiders	9.65%
Shares Institutions	19.73%
Shares Out	11,308,835
Shares Qo Q	0.27%
Shares Yo Y	-0.72%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	CAD 10.8M
Adjusted OCF	10,818,246
Average Volume	7,897.15x
Bv Per Share	4.04
CAPEX	CAD -45,642
Ch10y	90.85
Ch15y	5,205.1
Ch1m	4.33
Ch1w	-1.45
Ch1y	30.42
Ch20y	9,681.3
Ch3m	14.23
Ch3y	93.21
Ch5y	105.9
Ch6m	0.58
Change	-0.25%
Change From Open	-0.25
Close	15.69
Days Gap	0
Depreciation Amortization	1,663,460
Dollar Volume	69,329.5
Earnings Date	2026-08-20
EBIT	CAD 13.2M
EBITDA	CAD 14.9M
EPS	CAD 0.85
F Score	5
FCF	CAD 11.5M
FCF EV Yield	6.68x
FCF Per Share	CAD 1.01
Financing CF	-4,201,772
Fiscal Year End	December
Founded	2,006
Goodwill	3,796,739
Graham Number	8.81435
Graham Upside	-43.64
Income Tax	CAD 3.5M
Investing CF	-15,590,708
Is Primary Listing	1
Last Earnings Date	2026-08-20
Last Report Date	2026-06-30
Lynch Fair Value	CAD 15.42
Lynch Upside	-1.41
Ma150	14.73
Ma150ch	6.28%
Ma20	15.52
Ma20ch	0.86%
Net CF	-8,256,652
Next Earnings Date	2026-11-17
Open	15.69
P FCF Ratio	15.48
P FCF Ratio SBC	16.47
P OCF Ratio	15.42
P OCF Ratio SBC	16.4
Payment Date	2026-09-15
Position In Range	20
Ppne	1,538,613
Price Date	2026-09-10
Price EBITDA	CAD 11.92
Ptbv Ratio	9.12
Relative Volume	0.56x
Revenue	55,674,672x
SBC By Revenue	1.23x
Share Based Comp	686,083
Tax By Revenue	6.31x
Tax Rate	26.26%
Tr20y	10,417.76%
Tr6m	1.33%
Volume	4,430
Z Score	8.79

TSXV/RX (TSXV/RX)

Price

Financial snapshot

Fair-value bridge

Latest news · TSXV/RX

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All TSXV/RX indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Other indicators

Deeper analysis on TSXV/RX

Frequently asked questions